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Nano-sized extracellular vesicles (EVs), including exosomes, microvesicles, and other
types of vesicles, are released by most mammalian cells and bacteria. We here ask
whether feces contain EVs of mammalian and/or bacterial origin, and whether these
EVs induce systemic inflammation. Fecal extracellular vesicles (fEVs) were isolated
from mice and humans. The presence of EVs from Gram-negative and Gram-positive
bacteria was detected by enzyme-linked immunosorbent assay using anti-lipid A and
anti-lipoteichoic acid antibodies, whereas Western blot using anti-beta-actin antibody
was employed to detect host-derived EVs in the fEVs. Further, fEVs were administered
into mice by intraperitoneal injection, and inflammatory responses were investigated
in the peritoneum, blood, and lungs. The role of TLR2 and TLR4 were studied using
knockout mice. Significant quantities of EVs were present in feces from mice as well
as humans, and derived from Gram-negative and Gram-positive bacteria, as well
as the host. Bacteria-free fEVs introduced into the peritoneum induced local and
systemic inflammation (including in the lungs), but fEVs from germ-free animals had
weaker effects. This pronounced local and systemic inflammatory responses seemed
to be induced by EVs from both Gram-negative and Gram-positive bacteria, and was
attenuated in mice lacking TLR2 or TLR4. Our findings show that fEVs cause sepsis-like
systemic inflammation, when introduced intraperitoneally, a process regulated by TLR2
and TLR4.
Keywords: extracellular vesicles, exosomes, feces, membrane vesicles, outer membrane vesicles, sepsis-like
systemic inflammation
INTRODUCTION
The intestinal tract contains vast quantities of bacteria, and is exposed continuously to
environmental antigens and commensal microbes that normally live in a symbiotic and
mutually beneficial relationship with their hosts (O’Hara and Shanahan, 2006; Artis, 2008;
Hodges and Hecht, 2012). However, even a minute disruption of the barrier between the gut
lumen and peritoneum can induce severe local and systemic inflammatory responses, such as
peritonitis and sepsis, which are life-threatening conditions (Schein et al., 1997; Brook, 2003;
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Pieracci and Barie, 2007). When intestinal bacteria penetrate
from the gut lumen into the peritoneum, peritonitis is induced.
Overwhelming infection with intestinal bacteria will lead to
excessive activation of the immune responses, generalized
inflammation, hemodynamic instability, multiple organ
dysfunction, and eventually death (Deitch, 1992; Pieracci and
Barie, 2007).
However, not only whole bacteria, but also bacterial
membrane components alone, have the ability to induce severe
inflammatory responses in the mammalian hosts (Kuehn and
Kesty, 2005; Lee et al., 2008; Tashiro et al., 2012; Kim J.H.
et al., 2013; Park et al., 2013; Kim et al., 2015). Specifically, it
has recently been shown that nano-sized extracellular vesicles
(EVs) derived from Gram-negative bacteria, such as Escherichia
coli, can provoke severe immune responses and signs of
septic shock, without the presence of living bacteria (Park
et al., 2010; Shah et al., 2012). This effect is substantially
more potent than that of bacterial endotoxin lipopolysaccharide
(LPS) alone, suggesting that the presence of other bacterial
components strongly enhances the induced inflammation. It
is also known that membrane components derived from
Gram-positive bacteria can over-activate the immune responses
by binding to pattern-recognition receptors (Moreillon and
Majcherczyk, 2003; Hanson and Neely, 2012), and recently we
reported that Gram-positive bacteria, such as Staphylococcus
aureus, can also release EVs (Lee et al., 2009; Hong et al.,
2011).
The aim of the current study is to determine whether
EVs derived from feces can induce local and/or systemic
inflammatory responses if introduced into the peritoneal cavity,
and to which degree EVs from different types of bacteria
contribute to such effects. Thus, EVs were isolated from feces of
wild-type mice, germ-free mice, and humans (fecal extracellular
vesicles; fEVs), and characterized in relation to bacterial or host
sources. The isolated fEVs were introduced into the peritoneum,
and inflammatory responses were determined locally, in the
blood as well as in the lung, a distant organ. We also determined
the degree of inflammatory responses by macrophages treated
with fEVs and Gram-negative bacterial EV-removed fEVs.
Finally, the relative contribution of TLR2 and TLR4 in the




This study was carried out in accordance with the recom-
mendations of the Institutional Animal Care and Use
Committee at Pohang University of Science and Technology,
Pohang, South Korea. The protocol was approved by the
Institutional Animal Care and Use Committee at Pohang
University of Science and Technology (Approval number:
2011-01-0022). Wild-type and TLR4 KO of the C57BL/6
genetic background (6 weeks old) were purchased from
the Jackson Laboratory (Bar Harbor, ME, United States).
TLR2 KO mice and germ-free mice of the C57BL/6 genetic
background (6 weeks old) were obtained from Dr. Myoung
Ho Jang (Pohang University of Science and Technology),
and Dr. Charles D. Surh (Pohang University of Science and
Technology), respectively. Except the germ-free mice, mice
were reared under specific pathogen-free conditions in the
animal care facility of Pohang University of Science and
Technology. The germ-free mice were raised in sterile flexible
film isolators (Class Biologically Clean Ltd., Madison, WI,
United States).
Preparation of fEVs
Feces were collected from wild-type and germ-free mice or
four healthy male volunteers (27–30 years old) daily at the
same time, and stored at −80◦C until use. Mouse feces were
collected from the cage, and EVs derived from feces of germ-
free mice were used as “blank” isolations to quantitate baseline
of environmental EVs. For human fecal samples, as previously
reported (Oshiki et al., 2018), all volunteers provided oral consent
to provide the samples. All samples were anonymized and
there was no possibility of personal identification. About 35 g
of fecal materials were used for purification of fEVs for each
group. To prepare fEVs, feces were dissolved with phosphate-
buffered saline (PBS) at 4◦C for 10 min by inverting. About
4 mL of PBS were used to dissolve every gram of feces,
and no physical disruptions were needed to dissolve the feces
in PBS. Insoluble materials and cell debris were removed by
centrifugation at 800 × g for 5 min at 4◦C for three times,
and then centrifugation at 5,000 × g for 15 min at 4◦C for
three times. The supernatant was placed onto 1 mL of 0.8 M
sucrose and 2.5 M sucrose in HEPES-buffered saline (HBS;
20 mM HEPES, 150 mM NaCl, pH 7.4), and then centrifuged
at 100,000 × g for 2 h at 4◦C, using an ultracentrifuge
(Optima LE-80K; Beckman Coulter, Brea, CA, United States)
with SW32Ti rotor. The interface layer between 0.8 and 2.5 M
sucrose cushion was harvested and diluted 30-fold with PBS.
The diluted solution was filtered through a 0.45 µm pore-
sized filter, and the filtrate was placed onto 1 mL of 0.8 M
sucrose and 2.5 M sucrose in HBS, and then centrifuged at
100,000 × g for 2 h at 4◦C, using an ultracentrifuge (Optima
LE-80K) with SW41Ti rotor. Finally, fEVs were prepared by
taking the interface layer between 0.8 and 2.5 M sucrose cushion.
The protein concentration of fEVs was quantified by Bradford
assay (Bio-Rad Laboratories, Hercules, CA, United States). The
fEVs derived from wild-type mice, germ-free mice, and humans
were designated as MousefEVs, GFMousefEVs, and HumanfEVs,
respectively.
Mammalian Cell Culture and Colon26 EV
Preparation
Colon26 mouse colon adenocarcinoma (American Type Culture
Collection, ATCC; Manassas, VA, United States) and RAW264.7
mouse macrophages (ATCC) were cultured in minimum
essential medium (MEM; Gibco, Carlsbad, CA, United States)
and Dulbecco’s modified Eagle medium (DMEM; Gibco),
respectively. All culture media were supplemented with 10%
fetal bovine serum (FBS; Gibco), 100 units/mL penicillin, and
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0.1 mg/mL streptomycin. The cells were cultured at 37◦C with
5% CO2 in a humidified incubator.
To prepare EVs derived from Colon26, Colon26 cells were
rinsed twice with PBS, and incubated with serum-free MEM for
24 h. The conditioned medium was collected, and cell debris
was removed by centrifugation at 500 × g for 10 min at 4◦C,
and then at 2,000 × g for 15 min at 4◦C. The supernatant was
pelleted by centrifugation at 100,000 × g for 2 h at 4◦C, using an
ultracentrifuge (Optima LE-80K) with Type45Ti rotor (Beckman
Coulter, Brea, CA, United States). The pelleted Colon26 EVs were
resuspended with PBS, and stored at−80◦C until use.
Bacterial Culture and Bacterial EV
Preparation
Escherichia coli DH5α and S. aureus ATCC14458 were purchased
from ATCC. EVs derived from E. coli DH5α and S. aureus
ATCC14458 were prepared as previously described (Lee et al.,
2007, 2009). E. coli DH5α and S. aureus ATCC14458 were
cultured in 7.2 L of lysogeny broth (1% tryptone, 0.5% yeast
extract, 1% NaCl, pH 7.0; Merck, Darmstadt, Germany) or
nutrient broth (0.5% peptone, 0.3% meat extracts, pH 7.0;
Merck), respectively. Bacteria were cultured at 37◦C with
gentle shaking (150 rpm), until A600 = 1.5. Bacterial cultures
were centrifuged at 6,000 × g for 20 min at 4◦C, and the
supernatants were filtered through a 0.45 µm pore-sized vacuum
filter. The filtrates were concentrated by ultrafiltration with
QuixStand Benchtop System (GE Healthcare Life Sciences,
Pittsburgh, PA, United States) equipped with a 100 kDa
hollow-fiber membrane (GE Healthcare Life Sciences, Pittsburgh,
PA, United States). The retentates were filtered through a
0.22 µm pore-sized vacuum filter, to remove any remaining
cells. The resulting filtrates were pelleted by centrifugation
at 150,000 × g for 3 h at 4◦C, using an ultracentrifuge
(Optima LE-80K) with Type45Ti rotor (Beckman Coulter,
Brea, CA, United States), and resuspended with PBS. The
protein concentrations of the prepared EVs were quantified
with Bradford assay (Bio-Rad Laboratories, Hercules, CA,
United States).
Characterization of fEVs
To morphologically characterize the fEVs, the fEVs were
subjected to transmission electron microscopy (TEM). The
purified fEVs in PBS were placed on 400-mesh copper grids
(Electron Microscopy Services, Hatfield, PA, United States). The
fEV-absorbed grids were washed with deionizied water, and
negatively stained with 2% uranyl acetate (Ted Pella, Redding,
CA, United States). TEM images were acquired using JEM1011
electron microscope (JEOL, Tokyo, Japan) at an accelerating
voltage of 100 kV. To determine the size distribution of fEVs,
dynamic light scattering was performed with Zetasizer Nano
ZS (Malvern Instruments, Worcestershire, United Kingdom)
equipped with a 633 nm laser line, at the scattered intensity
for 10 × 30 s. For this analysis, the fEVs were diluted to a
total protein concentration of 5 µg/mL in 2 mL volume of PBS.
The measurement was obtained five times with 1 min intervals
at 25◦C.
To investigate origins of fEVs, enzyme-linked immunosorbent
assay (ELISA) and Western blot analyses were conducted.
For ELISA, various amounts of fEVs and EVs derived from
E. coli and S. aureus were coated on black opaque microtiter
plates (Greiner Bio-One Ltd., Frickenhausen, Germany). After
overnight incubation, the plates were blocked with 3% bovine
serum albumin/PBS for 2 h. To detect EVs derived from
Gram-negative and Gram-positive bacteria, anti-lipid A antibody
(Abcam, Cambridge, MA, United States) or anti-lipoteichoic
acid (LTA) antibody (Abcam, Cambridge, MA, United States)
was treated for 2 h, and then horseradish peroxidase-
conjugated secondary antibody was treated for 1 h. Relative
chemiluminescence was measured using a chemiluminescent
substrate (Roche Diagnostics GmbH, Mannheim, Germany).
For Western blot, fEVs (20 µg in total protein amounts) and
Colon26 EVs (30 µg in total protein amounts) were subjected
to sodium dodecyl sulfate-polyacrylamide gel electrophoresis,
and transferred to a polyvinylidene fluoride membrane. The
membrane was blocked with 3% skim milk/PBS for 2 h.
To detect host-derived EVs, anti-beta-actin antibody (Sigma-
Aldrich, St. Louis, MO, United States) was treated for 2 h, and
then horseradish peroxidase-conjugated secondary antibody was
treated for 1 h. The immunoreactive bands were detected with a
chemiluminescent substrate (iNtRON Biotechnology, Seongnam,
South Korea).
Protocol for fEV-Induced Inflammation in
Mice
To induce inflammation in mice, fEVs from wild-type mice,
germ-free mice, and humans (100 µg in total protein amounts)
were intraperitoneally administered into wild-type, TLR2 KO,
and TLR4 KO mice. At various time points (0, 3, 6, 12, and
24 h) after intraperitoneal administration of fEVs, the peritoneal
lavage fluid, blood, and bronchoalveolar lavage (BAL) fluid were
retrieved from the mice. As previously reported (Park et al., 2010;
Kim O.Y. et al., 2013), the peritoneal lavage fluid and BAL fluid
were harvested by instilling and aspirating two successive 1 mL of
PBS to the peritoneal cavity and bronchus, respectively, and the
blood was retrieved by cardiac puncture. The obtained samples
were centrifuged at 600× g for 10 min, then 1,500× g for 10 min,
and the supernatants were stored at −80◦C until measuring
cytokine concentrations. Tumor necrosis factor (TNF)-α and
interleukin (IL)-6 in the peritoneal lavage fluid, serum, and
BAL fluid were quantified by DuoSet ELISA kit (R&D Systems,
Minneapolis, MN, United States). The pelleted cells in the
peritoneal lavage fluid and BAL fluid were resuspended in 0.2 mL
of PBS, and counted using the light microscopy. Differential
count of cells in the peritoneal lavage fluid and BAL fluid were
quantified by counting 300 cells using a light microscope after
staining with Diff-Quik (Dade Behring, Marburg, Germany).
Inflammatory cells were classified as following: macrophages,
lymphocytes, neutrophils, and eosinophils.
Whole Body Imaging
After incubation of MousefEVs with Cy7-mono-NHS ester (5 µM,
GE Healthcare Life Sciences, Pittsburgh, PA, United States)
Frontiers in Microbiology | www.frontiersin.org 3 August 2018 | Volume 9 | Article 1735
fmicb-09-01735 August 3, 2018 Time: 18:24 # 4
Park et al. Fecal Extracellular Vesicle-Induced Systemic Inflammation
for 2 h at 37◦C, Cy7-labeled MousefEVs (MousefEVsCy7) were
isolated by centrifugation at 150,000 × g for 3 h at 4◦C, as
previously reported (Jang et al., 2015). Wild-type mice were
intraperitoneally administered with MousefEVsCy7 (100µg in total
protein amounts). Before administration, as well as at 10 min,
3, 6, 12, and 24 h after administration, Cy7 fluorescence in the
mice was measured by IVIS spectrum (Caliper Life Sciences,
Hopkinton, MA, United States) at Pohang Center for Evaluation
of Biomaterials, Pohang Technopark, Pohang, South Korea. At
3 and 24 h after administration, mice were sacrificed, and Cy7
fluorescence was quantified in organs including the liver, lung,
spleen, kidney, heart, and small intestine. Living Image 3.1
software (Perkin Elmer, Waltham, MA, United States) was used
to measure radiant efficiency, and the efficiency was normalized
by tissue weights.
Inhibition of TLR4 and Cytokine
Induction by Macrophages
To remove LPS-positive EVs in MousefEVs, MousefEVs were
applied to a polymyxin B column (Thermo Scientific, Rockford,
IL, United States), according to the manufacturer’s instructions.
The removal of LPS-positive EVs with retaining LTA-positive EVs
in MousefEVs were verified by ELISA using anti-lipid A antibody
(Abcam, Cambridge, MA, United States) and anti-LTA antibody
(Abcam, Cambridge, MA, United States).
RAW264.7 cells were seeded on a 24 well plate (5 × 104
cells/well), and were pre-incubated with vehicles or TLR4
antagonist [1 µg/mL; LPS from Rhodobacter sphaeroides
(InvivoGen, San Diego, CA, United States)] for 30 min at 37◦C.
Then, the cells were treated with MousefEVs (5 µg/mL in total
protein concentration) with 0.5% FBS for 15 h at 37◦C. The
conditioned media were harvested, and the concentrations of
TNF-α and IL-6 were measured by DuoSet ELISA Development
kit (R&D Systems).
Immunohistochemistry
At 3 h after intraperitoneal administration of MousefEVs (100 µg
in total protein amounts) into wild-type, TLR2 KO, and TLR4
KO mice, the lungs were excised after whole body perfusion. The
harvested lungs were fixed with 4% paraformaldehyde, embedded
in paraffin, sectioned (4 µm thickness), and deparaffinized.
The deparaffinized lungs were rehydrated by passage through
xylene and a grade alcohol series. After antigen retrieval was
performed by incubation in citrate buffer in a pressure cooker,
the lung sections were blocked with 5% horse serum/Tris-
buffered saline with 0.02% Triton X-100 for 2 h, and then treated
with anti-Ly6C/G (Abcam, Cambridge, MA, United States)
1:100, anti-SP-C (Santa Cruz Biotechnology, Santa Cruz, CA,
United States) 1:100, or anti-MousefEVs antibody (lab-made
polyclonal antibody from rabbits) 1 µg/mL for overnight at 4◦C.
After treatment of AlexaFluor-conjugated secondary antibody
for 2 h, the lung sections were counter-stained with Hoechst
(Sigma-Aldrich, St. Louis, Missouri, United States). All images
were acquired with an FV1000 Olympus confocal microscope
(Olympus, Tokyo, Japan), and analyzed with FV10-ASW 3.0
software (Olympus, Tokyo, Japan). The numbers of neutrophils
per field were measured by counting random fields in fluorescent
images from each lung tissue.
Statistical Analysis
The resulting values were expressed as mean and standard
error mean (SEM), and Student’s t-test was used to find any
significance. The level of statistical significance was higher than
95% confidence in all the analyses.
RESULTS
Purification and Characterization of fEVs
The fEVs were purified from feces of mice and humans, as
illustrated in Figure 1. After dissolving the feces with PBS,
insoluble materials and cell debris in feces were removed by serial
centrifugations. The fEVs were finally purified by two rounds
of sucrose cushion ultracentrifugation. The average amounts
(in total protein amounts) of MousefEVs, GFMousefEVs, and
HumanfEVs were 103.7± 8.9 µg, 70.1± 1.4 µg, and 45.7± 3.6 µg
were isolated from every gram of feces, respectively (Figure 2A).
The average diameters of MousefEVs, GFMousefEVs, and HumanfEVs
were 118.1 ± 11.3 nm, 140.9 ± 14.2 nm, and 120.5 ± 6.1 nm,
respectively, as determined through dynamic light scattering
(Figure 2B). TEM revealed that the purified fEVs were spherical
and appeared to have a closed membrane bilayer (Figure 2C).
We next investigated the origins of fEVs by identifying
the marker molecules for prokaryotes and eukaryotes. Lipid
A, the core component of Gram-negative bacterial endotoxin
LPS, was identified from MousefEVs, HumanfEVs, and E. coli EVs
(Figure 2D). Moreover, LTA, a component of Gram-positive
bacterial cell wall, was detected from MousefEVs, HumanfEVs, and
S. aureus EVs. However, GFMousefEVs and Colon26 EVs had
only scarce amount of lipid A and LTA. Western blot detected
beta-actin in all fEVs, as well as in Colon26 EVs (Figure 2E),
showing that substantial amounts of fEVs are likely to originate
from mammalian cells. Thus, the overall data suggest that fEVs
originate from both Gram-negative and Gram-positive bacteria,
as well as from their hosts.
Peritoneal, Systemic, and Pulmonary
Inflammation Induced by Intraperitoneal
Administration of MousefEVs and
HumanfEVs, but Not by GFMousefEVs
Various amounts of MousefEVs were intraperitoneally
administered to wild-type mice, resulting in the increase
of the concentrations of TNF-α and IL-6 in the peritoneal
lavage fluids in a dose-dependent manner (Figure 3A). As
100 µg MousefEVs in protein was sufficient to induce the
local inflammatory responses, we used 100 µg of fEVs in the
subsequent analyses. Intraperitoneal administration of MousefEVs
to wild-type mice resulted in a substantial increase of the
concentrations of TNF-α and IL-6 in the peritoneal lavage fluids
(Figure 3B), serum (Figure 3C), and BAL fluid (Figure 3D),
when compared to sham operation. The time-course of increases
in the concentrations of TNF-α and IL-6 by MousefEVs suggest
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FIGURE 1 | Schematic illustration of the purification methods of fecal extracellular vesicles (fEVs). The fEVs were isolated from feces of mice and humans as
illustrated. PBS, phosphate-buffered saline.
that the local and systemic responses are occurring within
hours and then subside, whereas the pulmonary response is
significantly retained for 24 h.
Next, we compared local and systemic inflammatory effects
of MousefEVs with GFMousefEVs and HumanfEVs. Intraperitoneal
administration of MousefEVs and HumanfEVs resulted in
a substantial increase in the peritoneal lavage fluid cells
(Figure 3E), cytokines (Figure 3F), serum cytokines (Figure 3G),
and BAL fluid cells (Figure 3H), and cytokines (Figure 3I), when
compared to sham operation. In contrast, GFMousefEVs did not
cause inflammation, suggesting that GFMousefEVs harbor few
bacterial components, so they do not induce inflammation.
Although the environmental contaminants can be contributed
to the recovered fEVs, the contribution might be negligible in
terms of proinflammatory effects of the fEVs, since GFMousefEVs
showed little if any proinflammatory effects, when compared
with MousefEVs.
Distribution of Intraperitoneally
Administered MousefEVs in Mice
Wild-type mice were intraperitoneally administrated with
MousefEVsCy7, to assess the distribution of MousefEVs in mice.
Whole body imaging showed strong accumulation of Cy7
fluorescence in the whole body at 3 h, and rare signals by 24 h
(Figure 4A). The distribution of Cy7 fluorescence in different
organs showed strong accumulation of Cy7 fluorescence in the
liver, lung, spleen, kidney, and heart at 3 h, and then subsided
(Figures 4B,C).
Effects of TLR2 and TLR4 on the
Responses to MousefEVs
To investigate the effect of depleting LPS-positive EVs from
Gram-negative bacteria on the inflammatory activity of
MousefEVs, MousefEVs were passed through a polymyxin B
column. This approach significantly reduced the concentration
of LPS-positive EVs from Gram-negative bacteria (Figure 5A).
In contrast, the concentration of LTA-positive EVs from Gram-
positive bacteria was not affected. Reduction of LPS-positive
EVs from Gram-negative bacteria from MousefEVs significantly
reduced the release of TNF-α and IL-6 from RAW264.7 cells
(Figures 5B,C; open bars). TLR4 antagonist significantly reduced
both the release of TNF-α and IL-6 induced by MousefEVs with
or without having passed through the polymyxin B column
(Figures 5B,C; closed bars), but the observed reduction was
greater when MousefEVs, which were not passed through the
polymyxin B column, were used. Although not as high as
MousefEVs treatment, treatment of MousefEVs having passed
through the polymyxin B column with TLR4 antagonist was
still able to induce the release of TNF-α and IL-6 by RAW264.7
cells (Figures 5B,C). All these observations suggest that both
Gram-negative and Gram-positive bacterial EVs should be
involved in MousefEV-induced inflammation.
We next investigated the roles of TLR2 and TLR4 in MousefEV-
induced local and systemic inflammation. Intraperitoneal
introduction of MousefEVs to TLR2 KO mice significantly
reduced the concentration of TNF-α in both the peritoneal
lavage fluids (Figure 5D) and serum (Figure 5E), but did
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FIGURE 2 | The fEVs originate from intestinal bacteria and the hosts. (A) The yields of fEVs measured in the total protein amounts (n = 3). (B) The size distribution of
the fEVs measured by dynamic light scattering (n = 5). (C) TEM images of the purified fEVs. Scale bars = 200 nm. (D) The fEVs were analyzed for the content of lipid
A (Gram-negative bacterial component) and LTA (Gram-positive bacterial component) by ELISA (RLU, relative luminescence unit) (n = 3). EVs derived from E. coli,
S. aureus, and Colon26 were used as controls for Gram-negative and Gram-positive bacterial as well as host origins, respectively. (E) The fEVs (20 µg in total protein
amounts) were analyzed by Western blot, using anti-beta-actin antibody, and Colon26 EVs (30 µg in total protein amounts) were used as controls for mouse origins.
Error bars indicate SEM.
not significantly reduce the concentration of IL-6 in either
compartment (Figures 5D,E), compared to wild-type mice.
Intraperitoneal introduction of MousefEVs to TLR4 KO mice
significantly reduced the concentrations of TNF-α and IL-
6 in both the peritoneal lavage fluids (Figure 5D) and
serum (Figure 5E), compared to wild-type mice. However,
intraperitoneal introduction of MousefEVs to TLR2 KO and TLR4
KO mice significantly reduced the number of peritoneal lavage
fluid cells, compared to wild-type mice (Figure 5D). In the
lungs, significant sequestration of neutrophils was observed by
the intraperitoneal introduction of MousefEVs in wild-type mice
(Figures 5F,G). A significant reduction in the sequestration of
neutrophils induced by MousefEVs was observed in TLR4 KO
mice, but not in TLR2 KO mice compared to wild-type mice
(Figure 5G). However, we were still able to observe the lung
inflammation induced by MousefEVs in both the TLR2 KO and
TLR4 KO mice.
DISCUSSION
This study shows that feces contain significant amounts of
fEVs, which are derived from both Gram-negative and Gram-
positive bacteria, as well as from the host itself (most likely
from intestinal epithelial cells). We further show that fEVs
have the capacity to induce local inflammation, as well as
systemic and pulmonary inflammation, when introduced in a
sterile way into the peritoneum. The intraperitoneally introduced
fEVs induced a neutrophilic peritoneal inflammation as well
as sequestration of neutrophils into the lung tissues, which
was further paralleled in a significant increase of airway
macrophages. The cellular inflammation was closely associated
with increased concentrations of TNF-α and IL-6, both locally
and systemically. Our study further showed that the local and
systemic inflammatory responses to fEVs in TLR2 KO and TLR4
KO mice were significantly reduced.
We showed that feces harbor EVs from both Gram-negative
and Gram-positive bacteria, since the fEVs contain lipid A and
LTA. Furthermore, a previous study reported the detection of
CD63-positive EVs in feces from three children infected with
rotavirus (Barreto et al., 2010), and our mouse study thus
confirmed the presence of EVs containing a mammalian protein,
beta-actin. Thus, fractions of the fEVs are likely to originate from
the host, and most probably from the intestinal epithelium. In
addition, considering that the gut microbiota is also constituted
by a vast mycobiota (Huseyin et al., 2017), and that fungi also
release EVs (Vallejo et al., 2012), fEVs could also be derived
from gut fungi. Morphologically, many fEVs detected in this
study were shown to be spherical and have a lipid bilayer. The
sizes of fEVs may be related to the origins of EVs. As germ-free
mice are devoid of fecal bacteria, GFMousefEVs do not contain
bacterial EVs, which are relatively smaller than host cell-derived
EVs. Thus, the average size of GFMousefEVs was bigger than those
of MousefEVs and HumanfEVs, which containing bacterial EVs.
Intraperitoneal introduction of the purified fEVs resulted in
a strong inflammatory response in the peritoneum, as well as in
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FIGURE 3 | Comparison of peritoneal, systemic, and pulmonary inflammation by MousefEVs, GFMousefEVs, and HumanfEVs. (A) Dose-dependent effects of
MousefEV-induced increase of the release of TNF-α and IL-6 in the peritoneal lavage fluid, after intraperitoneal introduction of MousefEVs (n = 5). (B–D) The time course
of MousefEV-induced increase of the release of TNF-α and IL-6 in the peritoneal lavage fluid (B), serum (C), and BAL fluid (D), after intraperitoneal introduction of
MousefEVs (100 µg in total protein amounts; n = 5). (E–I) At 3 h after intraperitoneal introduction of MousefEVs, GFMousefEVs, or HumanfEVs (100 µg in total protein
amounts; n = 5 for PBS and MousefEVs group, n = 3 for GFMousefEVs group, and n = 5 for HumanfEVs group), the number of inflammatory cells (E), and the
concentration of TNF-α and IL-6 in the peritoneal lavage fluid (F) were quantified. The concentration of TNF-α and IL-6 in the serum (G), the number of inflammatory
cells (H), and the concentration of TNF-α and IL-6 in the BAL fluid (I) were also measured. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001, respectively, when the data
were compared to 0 h or PBS group. Error bars indicate SEM.
the blood and the lungs. The local peritoneal inflammation, as
well as the signs of systemic and pulmonary inflammation, was
associated with a significant increase in the concentrations of
TNF-α and IL-6 in all three compartments. We have previously
shown that EVs from E. coli cultured in vitro could induce
sepsis-like systemic inflammatory responses in vivo (Park et al.,
2010), and the current study extend this finding by using feces,
which represents multiple gut microbiota, as starting materials.
Thus, this study suggests a putative pathogenic effect of EVs
that may penetrate the gut mucosa to reach the peritoneum. In
addition to our previous study with E. coli EVs, proinflammatory
effects of different bacterial EVs have previously been described
in EVs derived from Pseudomonas aeruginosa (Ellis et al., 2010;
Park et al., 2013), Salmonella enterica serovar Typhimurium
(Alaniz et al., 2007), Neisseria meningitidis (Bjerre et al., 2000),
Helicobacter pylori (Ismail et al., 2003), Moraxella catarrhalis
(Schaar et al., 2011), as well as Mycobacterium tuberculosis
(Prados-Rosales et al., 2011). In most of these previous studies,
the effects of the bacterial EVs have been studied either in vitro,
or by intravenous or intranasal administration of the EVs.
Thus, our current study is crucial, as it confirms that EVs of
bacterial origins administrated to a closed body compartment
could induce inflammation in a distant organ. Indeed, it has
previously been suggested that EVs of bacterial origins deliver
bacterial proteins at a distance (Bomberger et al., 2009), and it
has been shown that sepsis patients have EVs in the circulation
(Namork and Brandtzaeg, 2002). Furthermore, we have identified
the presence of fEVs, or fragments of these EVs, in the lungs
after intraperitoneal introduction. Although the small intestine
seems like to be close from the peritoneum, fEVs are likely
to be absorbed into the lymphatic vessels in the peritoneum
(Mactier et al., 1987), so less amounts of fEVs may be distributed
to the small intestine, when compared to other organs. Then,
the absorbed fEVs may get into the heart via the lymphatic
vessels and systemically distributed via the bloodstream. Like
other nanoparticles, fEVs are likely to be retained for a long time
in the organs with the developed reticuloendothelial systems,
such as the liver, lungs, and spleen. Overall, these findings
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FIGURE 4 | Distribution of intraperitoneally introduced MousefEVsCy7 in mice. The MousefEVsCy7 (100 µg in total protein amounts) were intraperitoneally introduced in
mice. The Cy7 fluorescence of the whole body (A) or various tissues (B) was acquired by IVIS spectrum. Radiant efficiency was measured using Living Image 3.1
software, and normalized to tissue weight (C). ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001, respectively, when the data were compared to PBS group. Error bars
indicate SEM (n = 3).
suggest that bacterial EVs that pass over the barrier function
of the intestine, for example during infections or inflammatory
diseases, could be distributed to other organs, and there cause an
inflammatory response. Interestingly, the responses in the lungs
to intraperitoneal introduction of fEVs resulted in an increase of
macrophages in the BAL fluid, and an aggregation of neutrophils
in the lung vasculature. It is not surprising that the neutrophils
that gather in the lung vessels are not mirrored by neutrophilia
in the BAL fluid, as it has previously been shown that neutrophils
that have sequestered in the lungs are very slow to traffic into the
lung tissues and bronchi (van Eeden et al., 2000). It has previously
been shown that intestinal bacteria can be translocated to the
extra-intestinal sites when the intestinal barrier ruptures in the
patients undergoing abdominal surgery or trauma (Reddy et al.,
2007). In such circumstances, bacteria or their components can
evoke systemic inflammation, which leads to sepsis. We also used
fEVs from humans to find meanings in the clinical circumstances.
However, it would be valuable to track in vivo mouse distribution
of human fEVs using Cy7-labeled human fEVs. Furthermore, the
compositional characterization of fEVs may also be beneficial
to further elucidate the mechanisms of inflammatory responses
induced by fEVs.
Mice lacking either TLR2 or TLR4 had significant reduction
in both the local and systemic inflammatory responses to
intraperitoneally introduced fEVs. TLR2 responds to a greater
extent to Gram-positive bacteria and LTA, whereas TLR4
responds to Gram-negative bacteria and LPS (Hennessy et al.,
2010). Thus, the attenuated inflammatory responses in both TLR
KO models suggest that EVs derived from both Gram-negative
and Gram-positive bacteria contribute in the responses to fEVs,
although it should be recognized that TLR2 can respond to some
degrees to Gram-negative bacterial components. Interestingly,
different degrees of the release of both TNF-α and IL-6 were
observed in the different KO models, suggesting that each of
these cytokines is regulated differently. Indeed, it has been
suggested that Gram-negative and Gram-positive bacteria induce
the release of TNF-α and IL-6 with different potencies (Hessle
et al., 2005; Elson et al., 2007), and it has previously been
suggested that TLR2 participate in the inflammatory responses
against bacterial EVs (Prados-Rosales et al., 2011). However, to
date, no in vivo studies have studied several pattern recognition
receptors in the same study of bacterial EVs, which may help
the relative contribution of these receptors in the inflammatory
responses.
We have previously shown that introducing E. coli EVs
intraperitoneally will lead to a sepsis-like death within 24 h (Park
et al., 2010). In the current study, we used a similar concentration
of EVs, but we did not observe the mortality seen in the previous
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FIGURE 5 | Both TLR2 and TLR4 contribute to systemic inflammation induced by MousefEVs. (A) After passing MousefEVs through a polymyxin B column, which
binds LPS, ELISA using anti-lipid A and anti-LTA antibodies showed efficient removal of LPS-positive EVs (Gram-negative bacterial EVs) in MousefEVs, but not of
LTA-positive EVs (Gram-positive bacterial EVs) (n = 3). (B,C) RAW264.7 cells were pre-incubated with vehicles (open bars) or TLR4 antagonist (closed bar; LPS from
Rhodobacter sphaeroides, 1 µg/mL) for 30 min, and treated with MousefEVs (5 µg/mL in total protein concentrations), which either had or had not passed through
the polymyxin B column, for 15 h, and the concentrations of TNF-α (B) and IL-6 (C) in the conditioned media were measured (n = 3). (D,E) Wild-type, TLR2 KO,
TLR4 KO mice were sacrificed at 3 h after intraperitoneal introduction of MousefEVs (100 µg in total protein amounts). The concentrations of TNF-α and IL-6 in the
peritoneal lavage fluids (D) and serum (E) were measured (n = 5). The number of inflammatory cells in the peritoneal lavage fluids were also quantified (D). (F,G)
Wild-type, TLR2 KO, TLR4 KO mice were sacrificed at 3 h after intraperitoneal introduction of MousefEVs (100 µg in total protein amounts). The lungs were excised
after whole body perfusion and immediately fixed with paraformaldehyde, sectioned at 4 µm thickness, and subsequently stained with markers for neutrophils
(anti-Ly6C/G antibody; green), and alveoli (anti-SP-C antibody; red). The lung images were acquired with a confocal microscope (F). Scale bar = 100 µm. The
numbers of Ly6C/G-positive cells per field were calculated (G) (n = 7). ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001, respectively, when the data were compared to (−)
or PBS group. Error bars indicate SEM.
study. This may be explained by the fact that fEVs contain lower
concentration of E. coli EVs, which may be more potent than
a mixture of EVs from feces. Furthermore, it is possible that
bacterial EVs contribute significantly to the pathophysiology of
systemic inflammatory response syndrome. Indeed, bacteremia
is not often detected in sepsis (Munford, 2006), which may
either be explained by insufficient culture techniques, or that the
syndrome is induced by EVs that are systemically distributed
from a local infection. Further studies using different approaches
will be required to determine the relative contribution of EVs and
whole bacteria in systemic inflammatory response syndrome.
This study for the first time shows that nano-sized EVs
from feces have the capacity to induce local and systemic
inflammation when introduced into the peritoneum. This
pronounced inflammatory response seems to be induced by
EVs from both Gram-negative and Gram-positive bacteria,
and attenuated in both TLR2 and TLR4 KO mice. Thus,
bacterial EVs in feces have strong proinflammatory properties,
and may contribute to some of the pathology seen in
sepsis.
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